It's a common storytelling trope: the stubborn foe who is eventually revealed to be a much-needed friend. Biology has its own ...

Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works.

Study uncovers key insights about how a new class of antiviral drugs works. Cryo-EM images showed the drugs bound to herpes simplex virus (HSV) protein at nearly atomic detail, while optical tweezers ...

Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...

As of Wednesday, December 24, Repare Therapeutics Inc.’s RPTX share price has surged by 19.82%, which has investors questioning if this is right time to sell.

Structures long blamed for blocking genes actually help them turn on, according to the Cornell Chronicle. Cornell scientists found that nucleosomes — the spools that package DNA — relieve twisting ...

PLAMseq utilizes a rapid biotinylation enzyme called TurboID, which tags nearby proteins, enabling the genomic loci and interacting proteome of a protein of interest to be identified in the same ...

Out of the 386 regencies and mayoralties targeted by the Health Ministry, fewer than half are estimated to have public health ...

Genomics drives climate resilience by revealing microbial impacts on Portuguese crops and supporting Amazonian pirarucu ...

Repare Therapeutics ( ($RPTX) ) has issued an update. On December 23, 2025, Repare Therapeutics entered into an asset purchase agreement under ...